Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 May 13:13:853999.
doi: 10.3389/fendo.2022.853999. eCollection 2022.

Melatonin Improves Quality of Repeated-Poor and Frozen-Thawed Embryos in Human, a Prospective Clinical Trial

Zhongjian Bao  1 , Guangdong Li  2 , Rongxiang Wang  3 , Songguo Xue  3 , Yong Zeng  4 , Shoulong Deng  5
Affiliations
Randomized Controlled Trial

Melatonin Improves Quality of Repeated-Poor and Frozen-Thawed Embryos in Human, a Prospective Clinical Trial

Zhongjian Bao et al. Front Endocrinol (Lausanne). .

Abstract

Objective: In this study, two experiments were performed to assess the effect and the role of melatonin on human in vitro embryo quality.

Methods: Experiment I: A total of 42 repeated-poor-quality-embryo patients were enrolled, with a total of 181 oocytes retrieval cycles. After IVF, for the same patient, the MT cycles group (10-7 M melatonin added to the culture medium; n=48) were compared with the previous non-MT cycles group (n=133), following by in vitro culture to blastocyst stage and embryo transfer. 31 patients were transplanted with 65 embryo transfer, including 24 MT embryo transfer, 41 non-MT embryo transfer. Cycle outcomes were compared between the two groups. Experiment II:A total of 143 supernumerary human cleavage-stage embryos (from non-repeated-poor-quality-embryo patients) vitrified on Day 3 after IVF were warmed and randomized into two groups: melatonin group (10-7 M melatonin added to the culture medium; n=71) and control group (n=72), and then cultured for 72 h. Rate of blastocyst and high-quality blastocyst, reactive oxygen species (ROS) levels of culture media as well as embryonic GPX1, CAT, Mn-SOD, Cu/Zn-SOD, BCL-2, BAX gene expression levels were analyzed.

Results: Experiment I: Results showed that the rate of Day 3 high-quality embryos (29.6% vs.19.5%) in the MT cycles group was significantly higher than that in the non-MT cycles group (P<0.05). The rate of available blastocysts (17.1% vs.12.7%) and clinical pregnancy rate (25.0% vs.17.1%) were in tendency higher in the group treated with melatonin (P>0.05). Experiment II:Results showed that the blastocyst rates in the melatonin administered group were significantly higher than in control group (42.25% vs.26.38%, P<0.05). There were no significant differences in high-quality blastocyst rates. In addition, quantitative PCR showed that the expression of CAT was significantly upregulated by melatonin treatment (P<0.05), while there were no significant differences in the expression of GPX1, Mn-SOD, Cu/Zn-SOD, BAX and BCL-2 gene as well as the levels of ROS.

Conclusion: These data showed that melatonin supplement in the culture medium will improve Day 3 high-quality embryos rate of repeated-poor-quality-embryo patients and improve blastocyst rate of vitrified-warmed cleavage-stage embryos, suggesting that melatonin intervention may provide a potential rescue strategy for IVF failures.

Clinical trial registration: identifier [ChiCTR2200059773].

Keywords: embryo quality; human; in vitro culture; melatonin; repeated-poor; vitrified-warmed.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The experimental flowchart.
Figure 2
Figure 2
Effects of melatonin on the ROS levels of culture media culturing vitrified-warmed human cleavage-stage embryos for 72 h. Control: the ROS levels of culture media supplemented with no melatonin; Melatonin: the ROS levels of culture media supplemented with 10-7 M melatonin.
Figure 3
Figure 3
Effects of melatonin on the gene expression of BCL-2, BAX, CAT, GPX1, Mn-SOD and Cu/Zn-SOD in vitrified-warmed human cleavage-stage embryos cultured for 72 h. *P < 0.05 compared with the control group.
See this image and copyright information in PMC

References

    1. Penzias AS. Recurrent IVF Failure: Other Factors. Fertil Steril (2012) 97:1033–8. doi: 10.1016/j.fertnstert.2012.03.017 - DOI - PubMed
    1. Sermondade N, Delarouzière V, Ravel C, Berthaut I, Verstraete L, Mathieu E, et al. . Characterization of a Recurrent Poor-Quality Embryo Morphology Phenotype and Zygote Transfer as a Rescue Strategy. Reprod BioMed Online (2012) 24:403–9. doi: 10.1016/j.rbmo.2012.01.004 - DOI - PubMed
    1. Bashiri A, Halper KI, Orvieto R. Recurrent Implantation Failure-Update Overview on Etiology, Diagnosis, Treatment and Future Directions. Reprod Biol Endocrin (2018) 16:1–18. doi: 10.1186/s12958-018-0414-2 - DOI - PMC - PubMed
    1. Fang C, Huang R, Li T, Jia L, Li L, Liang X. Day-2 and Day-3 Sequential Transfer Improves Pregnancy Rate in Patients With Repeated IVF–Embryo Transfer Failure: A Retrospective Case–Control Study. Reprod BioMed Online (2013) 26:30–5. doi: 10.1016/j.rbmo.2012.10.004 - DOI - PubMed
    1. Kaartinen N, Das P, Kananen K, Huhtala H, Tinkanen H. Can Repeated IVF–ICSI-Cycles be Avoided by Using Blastocysts Developing From Poor-Quality Cleavage Stage Embryos? Reprod BioMed Online (2015) 30:241–7. doi: 10.1016/j.rbmo.2014.11.016 - DOI - PubMed

Publication types